Investorideas.com
Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 


Investorideas podcasts on iTunes, Google Play Music and iHeart.com    Investorideas.com potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts    Investorideas.com crypto corner    Play by Play – the latest sports headlines and sports stock news

 

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories

Vitalhub Corp. (TSXV: VHI) Announces the Acquisition of Clarity Healthcare Solutions

 

Toronto, Ontario - January 17, 2018 (Newsfile Corp.) (Investorideas.com Newswire) VITALHUB CORP. (TSXV: VHI) (the "Company" or "Vitalhub"), is pleased to announce that it has acquired Clarity Healthcare Solutions and other selected assets of Clarity Health Inc. ("Clarity"), such assets having previously represented approximately $200,000 in revenue for Clarity in its last fiscal year (the "Acquisition") pursuant to an acquisition agreement (the "Agreement") dated January 17, 2018.

"We are excited to have the Clarity Healthcare Solution customers join the Vitalhub family of products," said Daniel Matlow, Chief Executive Officer of Vitalhub. "This is the third acquisition we have completed with similar solutions in the last three months. We continue to add synergistic and accretive solutions as we move forward with our M & A business plan."

The purchase price for the Acquisition is $353,883 satisfied by the delivery today, on closing of the Acquisition, of 2,527,735 common shares of Vitalhub ("Common Shares"), at a deemed price of $0.14 per Common Share (the "Share Purchase Price"), to Clarity.

In advance of closing the Acquisition, the Company had 122,357,974 Common Shares issued and outstanding. Upon delivery of the Share Purchase Price, the Company now has a total 124,885,709 issued and outstanding Common Shares. The Share Purchase Price is subject to escrow and is to be released in four equal amounts over the period of twelve (12) months beginning with the date that is three (3) months after the date of closing.

Concurrent with today's closing of the Acquisition, Clarity's principal, Saverio Rinaldi, has entered into a consulting agreement with Vitalhub to assist with the transition of Clarity Healthcare Solutions into Vitalhub's own suite of products.

"We are excited to be a part of Vitalhub, knowing that our clients will continue to be well served as we move forward together," said Saverio Rinaldi, Chief Executive Officer of Clarity Health Inc.

About Clarity Health Inc.

Clarity is a Canadian Healthcare software and consulting services company specializing in patient centric solutions. Clarity Healthcare Solutions a web-based interface and data entry solution used by leading healthcare organizations to perform in-patient assessments, as it streamlines resident assessments and reporting for complex continuing and long-term care providers. Its applications include Mental Health, Rehab and Homecare assessments.

About Vitalhub

Vitalhub delivers an innovate platform for the creation of mobile health applications that increases productivity within healthcare settings. The Vitalhub platform provides the ability to integrate existing individual healthcare applications while maintaining the control, security and privacy essential in healthcare. Vitalhub's applications are focused on the fast-growing mental health and long term care markets and the company plans to strategically acquire and grow business in these areas. Currently over 50 healthcare institutions across Canada use products from Vitalhub and its subsidiaries.

Vitalhub is based in Toronto, ON, and publicly traded on the TSX Venture Exchange: VHI.

For further information please contact:

Dan Matlow
Chief Executive Officer, and Director
(416) 727-9061
dan.matlow@vitalhub.com

Cautionary Statements

The TSX Venture Exchange has in no way passed upon the merits of the transactions and has neither approved nor disapproved the contents of this press release. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.


BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks

BiotechIndustryStocks.com - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks


More Info:

Investorideas.com Newswire

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire http://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp